Annual CAPEX:
$2.52B+$408.18M(+19.29%)Summary
- As of today, RPRX annual capital expenditures is $2.52 billion, with the most recent change of +$408.18 million (+19.29%) on December 31, 2024.
- During the last 3 years, RPRX annual CAPEX has risen by +$332.20 million (+15.16%).
- RPRX annual CAPEX is now at all-time high.
Performance
RPRX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
$961.87M+$960.76M(+86244.08%)Summary
- As of today, RPRX quarterly capital expenditures is $961.87 million, with the most recent change of +$960.76 million (+86244.08%) on September 30, 2025.
- Over the past year, RPRX quarterly CAPEX has dropped by -$232.70 million (-19.48%).
- RPRX quarterly CAPEX is now -28.00% below its all-time high of $1.34 billion, reached on September 30, 2021.
Performance
RPRX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$1.46B-$232.70M(-13.74%)Summary
- As of today, RPRX TTM capital expenditures is $1.46 billion, with the most recent change of -$232.70 million (-13.74%) on September 30, 2025.
- Over the past year, RPRX TTM CAPEX has dropped by -$1.57 billion (-51.79%).
- RPRX TTM CAPEX is now -51.79% below its all-time high of $3.03 billion, reached on September 30, 2024.
Performance
RPRX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
RPRX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +19.3% | -19.5% | -51.8% |
| 3Y3 Years | +15.2% | -26.9% | -12.2% |
| 5Y5 Years | +46.6% | +19.9% | -20.8% |
RPRX CAPEX Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +43.2% | -26.9% | >+9999.0% | -51.8% | +5.5% |
| 5Y | 5-Year | at high | +46.6% | -28.0% | >+9999.0% | -51.8% | +5.5% |
| All-Time | All-Time | at high | >+9999.0% | -28.0% | >+9999.0% | -51.8% | +138.5% |
RPRX CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $961.87M(>+9900.0%) | $1.46B(-13.7%) |
| Jun 2025 | - | $1.11M(+5.4%) | $1.69B(-30.6%) |
| Mar 2025 | - | $1.06M(-99.8%) | $2.44B(-3.4%) |
| Dec 2024 | $2.52B(+19.3%) | $496.42M(-58.4%) | $2.52B(-16.7%) |
| Sep 2024 | - | $1.19B(+60.0%) | $3.03B(+32.5%) |
| Jun 2024 | - | $746.63M(+767.3%) | $2.29B(+42.9%) |
| Mar 2024 | - | $86.08M(-91.4%) | $1.60B(-24.4%) |
| Dec 2023 | $2.12B(+20.0%) | $1.00B(+122.2%) | $2.12B(+52.8%) |
| Sep 2023 | - | $451.13M(+646.3%) | $1.38B(-38.5%) |
| Jun 2023 | - | $60.45M(-90.0%) | $2.25B(-4.8%) |
| Mar 2023 | - | $601.71M(+121.7%) | $2.36B(+34.1%) |
| Dec 2022 | $1.76B(-19.6%) | $271.46M(-79.4%) | $1.76B(+6.0%) |
| Sep 2022 | - | $1.32B(+652.1%) | $1.66B(-1.2%) |
| Jun 2022 | - | $175.01M(>+9900.0%) | $1.68B(-0.3%) |
| Mar 2022 | - | $85.00K(-100.0%) | $1.69B(-23.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $2.19B(+0.4%) | $171.73M(-87.1%) | $2.19B(-22.4%) |
| Sep 2021 | - | $1.34B(+639.5%) | $2.82B(+23.3%) |
| Jun 2021 | - | $180.67M(-64.1%) | $2.29B(-11.4%) |
| Mar 2021 | - | $503.07M(-37.5%) | $2.59B(+18.5%) |
| Dec 2020 | $2.18B(+26.8%) | $805.16M(+0.3%) | $2.18B(+18.4%) |
| Sep 2020 | - | $802.47M(+68.8%) | $1.84B(+73.3%) |
| Jun 2020 | - | $475.33M(+378.7%) | $1.06B(+73.8%) |
| Mar 2020 | - | $99.29M(-78.7%) | $612.31M(-64.4%) |
| Dec 2019 | $1.72B(+538.5%) | $466.77M(+1948.4%) | $1.72B(+37.2%) |
| Sep 2019 | - | $22.79M(-2.9%) | $1.25B(+1.8%) |
| Jun 2019 | - | $23.46M(-98.1%) | $1.23B(+1.9%) |
| Mar 2019 | - | $1.21B | $1.21B |
| Dec 2018 | $269.59M(-88.2%) | - | - |
| Dec 2017 | $2.29B(>+9900.0%) | - | - |
| Dec 2016 | $0.00(0.0%) | - | - |
| Dec 2015 | $0.00 | - | - |
FAQ
- What is Royalty Pharma plc annual capital expenditures?
- What is the all-time high annual CAPEX for Royalty Pharma plc?
- What is Royalty Pharma plc annual CAPEX year-on-year change?
- What is Royalty Pharma plc quarterly capital expenditures?
- What is the all-time high quarterly CAPEX for Royalty Pharma plc?
- What is Royalty Pharma plc quarterly CAPEX year-on-year change?
- What is Royalty Pharma plc TTM capital expenditures?
- What is the all-time high TTM CAPEX for Royalty Pharma plc?
- What is Royalty Pharma plc TTM CAPEX year-on-year change?
What is Royalty Pharma plc annual capital expenditures?
The current annual CAPEX of RPRX is $2.52B
What is the all-time high annual CAPEX for Royalty Pharma plc?
Royalty Pharma plc all-time high annual capital expenditures is $2.52B
What is Royalty Pharma plc annual CAPEX year-on-year change?
Over the past year, RPRX annual capital expenditures has changed by +$408.18M (+19.29%)
What is Royalty Pharma plc quarterly capital expenditures?
The current quarterly CAPEX of RPRX is $961.87M
What is the all-time high quarterly CAPEX for Royalty Pharma plc?
Royalty Pharma plc all-time high quarterly capital expenditures is $1.34B
What is Royalty Pharma plc quarterly CAPEX year-on-year change?
Over the past year, RPRX quarterly capital expenditures has changed by -$232.70M (-19.48%)
What is Royalty Pharma plc TTM capital expenditures?
The current TTM CAPEX of RPRX is $1.46B
What is the all-time high TTM CAPEX for Royalty Pharma plc?
Royalty Pharma plc all-time high TTM capital expenditures is $3.03B
What is Royalty Pharma plc TTM CAPEX year-on-year change?
Over the past year, RPRX TTM capital expenditures has changed by -$1.57B (-51.79%)